Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is ("Isolate-Inactivate-Inject") Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview.

Bragazzi NL, Gianfredi V, Villarini M, Rosselli R, Nasr A, Hussein A, Martini M, Behzadifar M.

Front Public Health. 2018 Mar 5;6:62. doi: 10.3389/fpubh.2018.00062. eCollection 2018. Review.

2.

Genetic diversity of pneumococcal surface protein A in invasive pneumococcal isolates from Korean children, 1991-2016.

Yun KW, Choi EH, Lee HJ.

PLoS One. 2017 Nov 13;12(11):e0183968. doi: 10.1371/journal.pone.0183968. eCollection 2017.

3.

Towards Identifying Protective B-Cell Epitopes: The PspA Story.

Khan N, Jan AT.

Front Microbiol. 2017 May 2;8:742. doi: 10.3389/fmicb.2017.00742. eCollection 2017. Review.

4.

Polyamine transporter in Streptococcus pneumoniae is essential for evading early innate immune responses in pneumococcal pneumonia.

Rai AN, Thornton JA, Stokes J, Sunesara I, Swiatlo E, Nanduri B.

Sci Rep. 2016 Jun 1;6:26964. doi: 10.1038/srep26964.

5.

A Brief Review of Computer-Assisted Approaches to Rational Design of Peptide Vaccines.

Nandy A, Basak SC.

Int J Mol Sci. 2016 May 4;17(5). pii: E666. doi: 10.3390/ijms17050666. Review.

6.

Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.

Greene CJ, Marks LR, Hu JC, Reddinger R, Mandell L, Roche-Hakansson H, King-Lyons ND, Connell TD, Hakansson AP.

Infect Immun. 2016 May 24;84(6):1693-1703. doi: 10.1128/IAI.01478-15. Print 2016 Jun.

7.

Diversity of Pneumolysin and Pneumococcal Histidine Triad Protein D of Streptococcus pneumoniae Isolated from Invasive Diseases in Korean Children.

Yun KW, Lee H, Choi EH, Lee HJ.

PLoS One. 2015 Aug 7;10(8):e0134055. doi: 10.1371/journal.pone.0134055. eCollection 2015.

8.

BMX: a tool for computing bacterial phyletic composition from orthologous maps.

Kulohoma BW.

BMC Res Notes. 2015 Feb 24;8:51. doi: 10.1186/s13104-015-1017-z.

9.

Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection in vivo.

Saxena S, Khan N, Dehinwal R, Kumar A, Sehgal D.

PLoS One. 2015 Feb 17;10(2):e0118154. doi: 10.1371/journal.pone.0118154. eCollection 2015.

10.
11.

Comparative genomics of the bacterial genus Streptococcus illuminates evolutionary implications of species groups.

Gao XY, Zhi XY, Li HW, Klenk HP, Li WJ.

PLoS One. 2014 Jun 30;9(6):e101229. doi: 10.1371/journal.pone.0101229. eCollection 2014.

12.

Glycotherapy: new advances inspire a reemergence of glycans in medicine.

Hudak JE, Bertozzi CR.

Chem Biol. 2014 Jan 16;21(1):16-37. doi: 10.1016/j.chembiol.2013.09.010. Epub 2013 Nov 21. Review.

13.

A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).

Genschmer KR, Accavitti-Loper MA, Briles DE.

Vaccine. 2013 Dec 17;32(1):39-47. doi: 10.1016/j.vaccine.2013.10.080. Epub 2013 Nov 6.

14.

Penicillin resistance and serotype distribution of Streptococcus pneumoniae in Ghanaian children less than six years of age.

Dayie NT, Arhin RE, Newman MJ, Dalsgaard A, Bisgaard M, Frimodt-Møller N, Slotved HC.

BMC Infect Dis. 2013 Oct 22;13:490. doi: 10.1186/1471-2334-13-490.

15.

Modified opsonization, phagocytosis, and killing assays to measure potentially protective antibodies against pneumococcal surface protein A.

Daniels CC, Kim KH, Burton RL, Mirza S, Walker M, King J, Hale Y, Coan P, Rhee DK, Nahm MH, Briles DE.

Clin Vaccine Immunol. 2013 Oct;20(10):1549-58. doi: 10.1128/CVI.00371-13. Epub 2013 Aug 7.

16.

Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.

Poland GA, Kennedy RB, McKinney BA, Ovsyannikova IG, Lambert ND, Jacobson RM, Oberg AL.

Semin Immunol. 2013 Apr;25(2):89-103. doi: 10.1016/j.smim.2013.04.007. Epub 2013 Jun 5. Review.

17.

Identification of genes that contribute to the pathogenesis of invasive pneumococcal disease by in vivo transcriptomic analysis.

Ogunniyi AD, Mahdi LK, Trappetti C, Verhoeven N, Mermans D, Van der Hoek MB, Plumptre CD, Paton JC.

Infect Immun. 2012 Sep;80(9):3268-78. doi: 10.1128/IAI.00295-12. Epub 2012 Jul 9.

18.

An evaluation of emerging vaccines for childhood pneumococcal pneumonia.

Webster J, Theodoratou E, Nair H, Seong AC, Zgaga L, Huda T, Johnson HL, Madhi S, Rubens C, Zhang JS, El Arifeen S, Krause R, Jacobs TA, Brooks AW, Campbell H, Rudan I.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S26. doi: 10.1186/1471-2458-11-S3-S26. Review.

19.

T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges.

Flower DR, Phadwal K, Macdonald IK, Coveney PV, Davies MN, Wan S.

Immunome Res. 2010 Nov 3;6 Suppl 2:S4. doi: 10.1186/1745-7580-6-S2-S4.

20.

The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.

Daniels CC, Coan P, King J, Hale J, Benton KA, Briles DE, Hollingshead SK.

Infect Immun. 2010 May;78(5):2163-72. doi: 10.1128/IAI.01199-09. Epub 2010 Mar 1.

Supplemental Content

Support Center